The Capital Grille
1338-46 Chestnut Street
Philadelphia, PA 19107
(215) 545-9588

Date: Thursday, May 19, 11:30 am. Luncheon presentation at noon.

Program Presenter: Jonathan Guarino, CPA, Senior Vice President and Chief Financial Officer


Jonathan Guarino, CPA, Senior Vice President and Chief Financial Officer

Jonathan Guarino has over 25 years of diverse experience in the financial and strategic management of emerging growth and commercial companies, including in the life sciences industry. Previously, he served as Corporate Controller for Hepion Pharmaceuticals, Inc. (formerly ContraVir Pharmaceuticals, Inc.), a New Jersey-based public biotechnology company, where he contributed to the establishment of the financial infrastructure, as well as assisted with capital fund-raising and debt financings. Previously, he worked as Controller and senior manager of technical accounting for Suite K Value Added Services LLC and Covance, Inc. Prior to these positions, he held accounting and finance positions of increasing importance with several companies, including PricewaterhouseCoopers LLP, BlackRock, Inc. and Barnes & Noble, Inc. Mr. Guarino is a CPA (certified public accountant) and CGMA (chartered global management accountant), who received his BS in Business from Montclair State University.


Soligenix, Inc. is a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need.

We have two areas of focus:

1) a specialized biotherapeutics segment dedicated to the development of products for orphan diseases and areas of unmet medical need such as cutaneous T-cell lymphoma, oral mucositis, pediatric Crohn’s disease, and psoriasis.

2) a public health solutions segment to develop vaccines and therapeutics for military and civilian applications in the areas of ricin exposure, emerging and antibiotic resistant infectious disease, and viral disease including Ebola, Marburg and COVID-19.